Industry Research Reports

Home > Reports > New Technology > Global Alzheimer Drug Market Research Report 2025

Global Alzheimer Drug Market Research Report 2025

Industry: New Technology

Published Date: 2025-01-01

Pages: 60 Pages

Report ld: 3453519

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Alzheimer Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Alzheimer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer Drug.

The Alzheimer Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Biogen
Eli Lilly
Alzheon

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Aducanumab
Donepezil
Rivastigmine
Memantine
Others

Segment by Application

Mild Alzheimer
Moderate Alzheimer
Severe Alzheimer

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alzheimer Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alzheimer Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Aducanumab

1.2.3 Donepezil

1.2.4 Rivastigmine

1.2.5 Memantine

1.2.6 Others

1.3 Market by Application

1.3.1 Global Alzheimer Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Mild Alzheimer

1.3.3 Moderate Alzheimer

1.3.4 Severe Alzheimer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alzheimer Drug Market Perspective (2020-2031)

2.2 Global Alzheimer Drug Growth Trends by Region

2.2.1 Global Alzheimer Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Alzheimer Drug Historic Market Size by Region (2020-2025)

2.2.3 Alzheimer Drug Forecasted Market Size by Region (2026-2031)

2.3 Alzheimer Drug Market Dynamics

2.3.1 Alzheimer Drug Industry Trends

2.3.2 Alzheimer Drug Market Drivers

2.3.3 Alzheimer Drug Market Challenges

2.3.4 Alzheimer Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Alzheimer Drug Players by Revenue

3.1.1 Global Top Alzheimer Drug Players by Revenue (2020-2025)

3.1.2 Global Alzheimer Drug Revenue Market Share by Players (2020-2025)

3.2 Global Alzheimer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Alzheimer Drug Revenue

3.4 Global Alzheimer Drug Market Concentration Ratio

3.4.1 Global Alzheimer Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer Drug Revenue in 2024

3.5 Global Key Players of Alzheimer Drug Head office and Area Served

3.6 Global Key Players of Alzheimer Drug, Product and Application

3.7 Global Key Players of Alzheimer Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer Drug Breakdown Data by Type

4.1 Global Alzheimer Drug Historic Market Size by Type (2020-2025)

4.2 Global Alzheimer Drug Forecasted Market Size by Type (2026-2031)

5 Alzheimer Drug Breakdown Data by Application

5.1 Global Alzheimer Drug Historic Market Size by Application (2020-2025)

5.2 Global Alzheimer Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Alzheimer Drug Market Size (2020-2031)

6.2 North America Alzheimer Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Alzheimer Drug Market Size by Country (2020-2025)

6.4 North America Alzheimer Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Alzheimer Drug Market Size (2020-2031)

7.2 Europe Alzheimer Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Alzheimer Drug Market Size by Country (2020-2025)

7.4 Europe Alzheimer Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Alzheimer Drug Market Size (2020-2031)

8.2 Asia-Pacific Alzheimer Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Alzheimer Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Alzheimer Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Alzheimer Drug Market Size (2020-2031)

9.2 Latin America Alzheimer Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Alzheimer Drug Market Size by Country (2020-2025)

9.4 Latin America Alzheimer Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Alzheimer Drug Market Size (2020-2031)

10.2 Middle East & Africa Alzheimer Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Alzheimer Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Alzheimer Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Details

11.1.2 Biogen Business Overview

11.1.3 Biogen Alzheimer Drug Introduction

11.1.4 Biogen Revenue in Alzheimer Drug Business (2020-2025)

11.1.5 Biogen Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Details

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Alzheimer Drug Introduction

11.2.4 Eli Lilly Revenue in Alzheimer Drug Business (2020-2025)

11.2.5 Eli Lilly Recent Development

11.3 Alzheon

11.3.1 Alzheon Company Details

11.3.2 Alzheon Business Overview

11.3.3 Alzheon Alzheimer Drug Introduction

11.3.4 Alzheon Revenue in Alzheimer Drug Business (2020-2025)

11.3.5 Alzheon Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Alzheimer Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Aducanumab

Table 3. Key Players of Donepezil

Table 4. Key Players of Rivastigmine

Table 5. Key Players of Memantine

Table 6. Key Players of Others

Table 7. Global Alzheimer Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Alzheimer Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Alzheimer Drug Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Alzheimer Drug Market Share by Region (2020-2025)

Table 11. Global Alzheimer Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Alzheimer Drug Market Share by Region (2026-2031)

Table 13. Alzheimer Drug Market Trends

Table 14. Alzheimer Drug Market Drivers

Table 15. Alzheimer Drug Market Challenges

Table 16. Alzheimer Drug Market Restraints

Table 17. Global Alzheimer Drug Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Alzheimer Drug Market Share by Players (2020-2025)

Table 19. Global Top Alzheimer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Drug as of 2024)

Table 20. Ranking of Global Top Alzheimer Drug Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Alzheimer Drug Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Alzheimer Drug, Headquarters and Area Served

Table 23. Global Key Players of Alzheimer Drug, Product and Application

Table 24. Global Key Players of Alzheimer Drug, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Alzheimer Drug Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Alzheimer Drug Revenue Market Share by Type (2020-2025)

Table 28. Global Alzheimer Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Alzheimer Drug Revenue Market Share by Type (2026-2031)

Table 30. Global Alzheimer Drug Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Alzheimer Drug Revenue Market Share by Application (2020-2025)

Table 32. Global Alzheimer Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Alzheimer Drug Revenue Market Share by Application (2026-2031)

Table 34. North America Alzheimer Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Alzheimer Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Alzheimer Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Alzheimer Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Alzheimer Drug Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Alzheimer Drug Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Alzheimer Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Alzheimer Drug Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Alzheimer Drug Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Alzheimer Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Alzheimer Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Alzheimer Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Alzheimer Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Alzheimer Drug Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Alzheimer Drug Market Size by Country (2026-2031) & (US$ Million)

Table 49. Biogen Company Details

Table 50. Biogen Business Overview

Table 51. Biogen Alzheimer Drug Product

Table 52. Biogen Revenue in Alzheimer Drug Business (2020-2025) & (US$ Million)

Table 53. Biogen Recent Development

Table 54. Eli Lilly Company Details

Table 55. Eli Lilly Business Overview

Table 56. Eli Lilly Alzheimer Drug Product

Table 57. Eli Lilly Revenue in Alzheimer Drug Business (2020-2025) & (US$ Million)

Table 58. Eli Lilly Recent Development

Table 59. Alzheon Company Details

Table 60. Alzheon Business Overview

Table 61. Alzheon Alzheimer Drug Product

Table 62. Alzheon Revenue in Alzheimer Drug Business (2020-2025) & (US$ Million)

Table 63. Alzheon Recent Development

Table 64. Research Programs/Design for This Report

Table 65. Key Data Information from Secondary Sources

Table 66. Key Data Information from Primary Sources

Table 67. Authors List of This Report

List of Figures

Figure 1. Alzheimer Drug Picture

Figure 2. Global Alzheimer Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Alzheimer Drug Market Share by Type: 2024 VS 2031

Figure 4. Aducanumab Features

Figure 5. Donepezil Features

Figure 6. Rivastigmine Features

Figure 7. Memantine Features

Figure 8. Others Features

Figure 9. Global Alzheimer Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Alzheimer Drug Market Share by Application: 2024 VS 2031

Figure 11. Mild Alzheimer Case Studies

Figure 12. Moderate Alzheimer Case Studies

Figure 13. Severe Alzheimer Case Studies

Figure 14. Alzheimer Drug Report Years Considered

Figure 15. Global Alzheimer Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Alzheimer Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Alzheimer Drug Market Share by Region: 2024 VS 2031

Figure 18. Global Alzheimer Drug Market Share by Players in 2024

Figure 19. Global Top Alzheimer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Drug as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Alzheimer Drug Revenue in 2024

Figure 21. North America Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Alzheimer Drug Market Share by Country (2020-2031)

Figure 23. United States Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Alzheimer Drug Market Share by Country (2020-2031)

Figure 27. Germany Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Alzheimer Drug Market Share by Region (2020-2031)

Figure 35. China Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Alzheimer Drug Market Share by Country (2020-2031)

Figure 43. Mexico Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Alzheimer Drug Market Share by Country (2020-2031)

Figure 47. Turkey Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Alzheimer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Biogen Revenue Growth Rate in Alzheimer Drug Business (2020-2025)

Figure 51. Eli Lilly Revenue Growth Rate in Alzheimer Drug Business (2020-2025)

Figure 52. Alzheon Revenue Growth Rate in Alzheimer Drug Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Alzheimer Drug market? zhanKai

The top companies in the global Alzheimer Drug market are Biogen、Eli Lilly、Alzheon.

Related Reports

Global Alzheimer Drug Market Insights, Forecast to 2030
Market Analysis and Insights: Global Alzheimer Drug Market
Published Date: 2024-04-12
Pages: 75
USD 4900.00
(Single User License)
Global Alzheimer Drug Market Research Report 2024
The global Alzheimer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 60
USD 2900.00
(Single User License)
Alzheimer Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Alzheimer Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-10
Pages: 74
USD 3950.00
(Single User License)

Global Alzheimer Drug Market Insights, Forecast to 2030
Market Analysis and Insights: Global Alzheimer Drug Market
Published: 2024-04-12
Pages: 75
USD 4900.00 (Single User License)
Global Alzheimer Drug Market Research Report 2024
The global Alzheimer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 60
USD 2900.00 (Single User License)
Alzheimer Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Alzheimer Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-10
Pages: 74
USD 3950.00 (Single User License)